As standards around interoperability emerge, now may be the time to look at the benefits of connected technologies.
Artificial intelligence is here to stay, but its ultimate success hinges on how it is deployed.
A look at where tech developments are originating and what to expect.
Procedures for design validation must address risk analysis where appropriate.
MRI-compatible pacemakers are among the technologies gaining traction.
Research and development activities to find potential treatments using next generation sequencing for various fatal conditions including melanoma, epilepsy, antibody deficiency, and other diseases have gained traction. In April, FDA finalized two guidance documents to speed up development of NGS-based tests.
Treating adhesive selection as a trivial exercise can result in manufacturing issues, device malfunctions and potential patient harm.
Validation is an obstacle to implementing technology. A streamlined approach is necessary.
With the heightened supplier scrutiny, it’s time to reevaluate your supplier quality program.
Before accepting money, the following is a guide to your due diligence process.